Marty holds a PhD in Bioengineering from UC San Diego, where he specialized in biomaterials for cardiovascular repair. He has held leadership roles at two early-stage startups: one in Japan developing an autologous cell therapy for late-stage heart failure, where he led global strategy and regulatory planning; and another as the first hire and Director of R&D, advancing a sprayable hydrogel device to prevent postsurgical adhesions. More recently, he returned to UC San Diego to support large-scale translational research through high-impact grant writing (>$75M in submissions), bridging science, clinical translation, and commercialization.